Clinical trials
Completed Basal Ganglia Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| Juvantia Pharma Ltd | 1 |
| Neurocrine Biosciences | 1 |
| Oregon Health and Science University | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Siena Biotech S.p.A. | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Ganglia Diseases | 8 |
| Movement Disorders | 8 |
| Brain Diseases | 6 |
| Central Nervous System Diseases | 6 |
| Parkinson Disease | 5 |
| Nervous System Diseases | 4 |
| Neurodegenerative Diseases | 4 |
| Mental Disorders | 3 |
| Dyskinesias | 2 |
| Huntington Disease | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.